Fundacion Favaloro

Study findings on angiotensins are outlined in reports from R.A. Sanchez and colleagues.
Blood Weekly; 12/25/2008; 1161 words; ...Additional information can be obtained by contacting R.A. Sanchez, Hypertension Section and Metabolic Unit, Fundacion Favaloro, Buenos Aires, Argentina. The publisher of the Journal of Hypertension can be contacted at: Lippincott Williams...

TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent.(Clinical report)
Heart Disease Weekly; 9/21/2008; 1297 words; ...in the largest, prospective DES patient population ever studied for an individual stent," said Dr. Mendiz, Fundacion Favaloro, Buenos Aires, Argentina. "The low occurrence of cardiac events and stent thrombosis is noteworthy, especially...

TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent.
PR Newswire; 9/2/2008; 1594 words; ...in the largest, prospective DES patient population ever studied for an individual stent," said Dr. Mendiz, Fundacion Favaloro, Buenos Aires, Argentina. "The low occurrence of cardiac events and stent thrombosis is noteworthy, especially...

LARGEST DRUG-ELUTING STENT REGISTRY REACHES HALFWAY POINT.
AsiaPulse News; 9/1/2006; 1291 words; ...Arabia, coordinating investigator of Phase I and also co-chairing Phase II with Oscar A. Mendiz, M.D., at Fundacion Favaloro in Buenos Aires, Argentina. "We are excited to have the TAXUS Liberte stent system available to treat our patients...

World's Largest Drug-Eluting Stent Registry Reaches Halfway Point in Enrollment.
PR Newswire; 8/31/2006; 1220 words; ...Arabia, coordinating investigator of Phase I and also co-chairing Phase II with Oscar A. Mendiz, M.D., at Fundacion Favaloro in Buenos Aires, Argentina. "We are excited to have the TAXUS Liberte stent system available to treat our patients...